Drug Profile
Radafaxine
Alternative Names: '162; 353162; Bupropion metabolite; GW 353162Latest Information Update: 21 Jan 2008
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antidepressants; Anxiolytics; Propiophenones; Small molecules
- Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bipolar disorders; Fibromyalgia; Major depressive disorder; Neuropathic pain; Obesity; Restless legs syndrome
Most Recent Events
- 03 Aug 2006 Discontinued - Phase-II for Depression in United Kingdom (unspecified route)
- 06 Dec 2005 Phase-I clinical trials in Obesity in United Kingdom (unspecified route)
- 22 Apr 2005 Phase-I clinical trials in Neuropathic pain in United Kingdom (unspecified route)